Pharmaceutical

Uveitis market expected to reach $1.5bn across 7MM by 2033

Late-stage pipeline products anticipated to reach the uveitis market during the forecast period will introduce new mechanisms of action.

Apr 6, 2025 - 06:00
Uveitis market expected to reach $1.5bn across 7MM by 2033
Late-stage pipeline products anticipated to reach the uveitis market during the forecast period will introduce new mechanisms of action.
Read the original article

Tags:

Previous Article

Triple Therapy Demonstrates Potential to Inhibit Glioblastoma Progression and Pr...

Next Article

Daiichi and AstraZeneca’s Enhertu gains EC approval for breast cancers

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Viking Therapeutics obesity drug hits target in key study, raising hopes for a competitor to existing medicines

STAT+: Viking Therapeutics obesity drug hits target in ...

Feb 27, 2024

2seventy bio completes $40m haemophilia A program deal with Novo Nordisk

2seventy bio completes $40m haemophilia A program deal ...

Jun 28, 2024

STAT+: Intas Pharma employee used acid to destroy manufacturing records at troubled plant

STAT+: Intas Pharma employee used acid to destroy manuf...

Aug 1, 2023